CA2597972A1 - Methode et composition de traitement du diabete - Google Patents

Methode et composition de traitement du diabete Download PDF

Info

Publication number: CA2597972A1
Authority: CA; Canada
Prior art keywords: blood; cells; tvemf; expanded; stem cells
Prior art date: 2007-08-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002597972A

Other languages

English (en)

Inventor

David Wolf

Donnie Rudd

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Regenetech Inc

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-08-20

Filing date

2007-08-20

Publication date

2009-02-20

2007-08-20 Application filed by Individual filed Critical Individual

2007-08-20 Priority to CA002597972A priority Critical patent/CA2597972A1/fr

2009-02-20 Publication of CA2597972A1 publication Critical patent/CA2597972A1/fr

Status Abandoned legal-status Critical Current

Links

239000000203 mixture Substances 0.000 title claims abstract description 127
238000000034 method Methods 0.000 title claims abstract description 99
206010012601 diabetes mellitus Diseases 0.000 title claims description 38
210000004027 cell Anatomy 0.000 claims abstract description 330
210000004369 blood Anatomy 0.000 claims abstract description 282
239000008280 blood Substances 0.000 claims abstract description 282
210000000130 stem cell Anatomy 0.000 claims abstract description 189
241000124008 Mammalia Species 0.000 claims description 52
210000001519 tissue Anatomy 0.000 claims description 48
210000000601 blood cell Anatomy 0.000 claims description 37
102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims description 30
101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims description 30
210000005259 peripheral blood Anatomy 0.000 claims description 30
239000011886 peripheral blood Substances 0.000 claims description 29
210000004700 fetal blood Anatomy 0.000 claims description 27
210000004504 adult stem cell Anatomy 0.000 claims description 26
231100000331 toxic Toxicity 0.000 claims description 22
230000002588 toxic effect Effects 0.000 claims description 22
210000003743 erythrocyte Anatomy 0.000 claims description 19
239000000463 material Substances 0.000 claims description 17
210000002381 plasma Anatomy 0.000 claims description 17
238000011282 treatment Methods 0.000 claims description 16
210000004923 pancreatic tissue Anatomy 0.000 claims description 15
230000014509 gene expression Effects 0.000 claims description 14
230000001747 exhibiting effect Effects 0.000 claims description 13
210000000496 pancreas Anatomy 0.000 claims description 9
102000009027 Albumins Human genes 0.000 claims description 8
108010088751 Albumins Proteins 0.000 claims description 8
239000000872 buffer Substances 0.000 claims description 8
239000003937 drug carrier Substances 0.000 claims description 8
210000004976 peripheral blood cell Anatomy 0.000 claims description 8
239000000725 suspension Substances 0.000 claims description 8
206010067584 Type 1 diabetes mellitus Diseases 0.000 claims description 7
230000000735 allogeneic effect Effects 0.000 claims description 7
208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 5
210000000683 abdominal cavity Anatomy 0.000 claims description 4
238000002360 preparation method Methods 0.000 claims description 4
230000005428 wave function Effects 0.000 claims description 4
102000003746 Insulin Receptor Human genes 0.000 claims description 3
108010001127 Insulin Receptor Proteins 0.000 claims description 3
210000001367 artery Anatomy 0.000 claims description 3
239000003814 drug Substances 0.000 claims description 3
230000007257 malfunction Effects 0.000 claims description 3
238000002156 mixing Methods 0.000 claims description 3
210000003200 peritoneal cavity Anatomy 0.000 claims description 3
210000004303 peritoneum Anatomy 0.000 claims description 3
230000036962 time dependent Effects 0.000 claims description 2
101000746367 Homo sapiens Granulocyte colony-stimulating factor Proteins 0.000 claims 1
101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 claims 1
102000046157 human CSF2 Human genes 0.000 claims 1
230000003068 static effect Effects 0.000 claims 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 18
201000010099 disease Diseases 0.000 abstract description 15
108090000623 proteins and genes Proteins 0.000 description 28
239000000523 sample Substances 0.000 description 28
239000001963 growth medium Substances 0.000 description 26
230000008439 repair process Effects 0.000 description 26
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 24
239000000126 substance Substances 0.000 description 23
230000008569 process Effects 0.000 description 22
239000012530 fluid Substances 0.000 description 21
230000035899 viability Effects 0.000 description 21
238000005138 cryopreservation Methods 0.000 description 20
230000006870 function Effects 0.000 description 20
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
210000002540 macrophage Anatomy 0.000 description 18
238000004062 sedimentation Methods 0.000 description 16
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 15
238000007710 freezing Methods 0.000 description 15
230000008014 freezing Effects 0.000 description 15
239000000243 solution Substances 0.000 description 15
238000004113 cell culture Methods 0.000 description 14
238000001816 cooling Methods 0.000 description 12
102000004169 proteins and genes Human genes 0.000 description 12
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 11
239000010949 copper Substances 0.000 description 11
229910052802 copper Inorganic materials 0.000 description 11
239000003102 growth factor Substances 0.000 description 11
210000001616 monocyte Anatomy 0.000 description 11
230000035882 stress Effects 0.000 description 11
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 10
102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 10
108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 10
239000006143 cell culture medium Substances 0.000 description 10
230000005484 gravity Effects 0.000 description 10
239000002609 medium Substances 0.000 description 10
230000017423 tissue regeneration Effects 0.000 description 10
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
102000008100 Human Serum Albumin Human genes 0.000 description 9
108091006905 Human Serum Albumin Proteins 0.000 description 9
210000001185 bone marrow Anatomy 0.000 description 9
239000000306 component Substances 0.000 description 9
-1 cryopreservatives Substances 0.000 description 9
239000002577 cryoprotective agent Substances 0.000 description 9
238000003359 percent control normalization Methods 0.000 description 9
238000011160 research Methods 0.000 description 9
238000002054 transplantation Methods 0.000 description 9
239000002699 waste material Substances 0.000 description 9
230000015572 biosynthetic process Effects 0.000 description 8
239000002738 chelating agent Substances 0.000 description 8
230000002338 cryopreservative effect Effects 0.000 description 8
230000006378 damage Effects 0.000 description 8
210000001671 embryonic stem cell Anatomy 0.000 description 8
229940088597 hormone Drugs 0.000 description 8
235000015097 nutrients Nutrition 0.000 description 8
238000011069 regeneration method Methods 0.000 description 8
230000001105 regulatory effect Effects 0.000 description 8
238000003860 storage Methods 0.000 description 8
108010052285 Membrane Proteins Proteins 0.000 description 7
230000001413 cellular effect Effects 0.000 description 7
210000003714 granulocyte Anatomy 0.000 description 7
239000005556 hormone Substances 0.000 description 7
230000028993 immune response Effects 0.000 description 7
210000000265 leukocyte Anatomy 0.000 description 7
230000000670 limiting effect Effects 0.000 description 7
229910052757 nitrogen Inorganic materials 0.000 description 7
230000002829 reductive effect Effects 0.000 description 7
230000008929 regeneration Effects 0.000 description 7
238000010257 thawing Methods 0.000 description 7
102000004127 Cytokines Human genes 0.000 description 6
108090000695 Cytokines Proteins 0.000 description 6
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
238000007792 addition Methods 0.000 description 6
239000000654 additive Substances 0.000 description 6
229910002092 carbon dioxide Inorganic materials 0.000 description 6
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
230000000694 effects Effects 0.000 description 6
239000008103 glucose Substances 0.000 description 6
208000014674 injury Diseases 0.000 description 6
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
239000007788 liquid Substances 0.000 description 6
102000005962 receptors Human genes 0.000 description 6
108020003175 receptors Proteins 0.000 description 6
238000012360 testing method Methods 0.000 description 6
108091023040 Transcription factor Proteins 0.000 description 5
102000040945 Transcription factor Human genes 0.000 description 5
230000004663 cell proliferation Effects 0.000 description 5
230000003247 decreasing effect Effects 0.000 description 5
230000004069 differentiation Effects 0.000 description 5
229940088598 enzyme Drugs 0.000 description 5
239000012737 fresh medium Substances 0.000 description 5
239000007789 gas Substances 0.000 description 5
230000003993 interaction Effects 0.000 description 5
210000004153 islets of langerhan Anatomy 0.000 description 5
230000033001 locomotion Effects 0.000 description 5
238000005259 measurement Methods 0.000 description 5
210000004379 membrane Anatomy 0.000 description 5
239000012528 membrane Substances 0.000 description 5
230000002503 metabolic effect Effects 0.000 description 5
238000012546 transfer Methods 0.000 description 5
102000004190 Enzymes Human genes 0.000 description 4
108090000790 Enzymes Proteins 0.000 description 4
206010061218 Inflammation Diseases 0.000 description 4
102100026966 Thrombomodulin Human genes 0.000 description 4
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
239000001569 carbon dioxide Substances 0.000 description 4
230000010261 cell growth Effects 0.000 description 4
210000000170 cell membrane Anatomy 0.000 description 4
230000008878 coupling Effects 0.000 description 4
238000010168 coupling process Methods 0.000 description 4
238000005859 coupling reaction Methods 0.000 description 4
230000003436 cytoskeletal effect Effects 0.000 description 4
230000001086 cytosolic effect Effects 0.000 description 4
238000002474 experimental method Methods 0.000 description 4
230000003394 haemopoietic effect Effects 0.000 description 4
210000000987 immune system Anatomy 0.000 description 4
230000004054 inflammatory process Effects 0.000 description 4
238000002347 injection Methods 0.000 description 4
239000007924 injection Substances 0.000 description 4
FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 4
238000012423 maintenance Methods 0.000 description 4
230000007246 mechanism Effects 0.000 description 4
239000001301 oxygen Substances 0.000 description 4
229910052760 oxygen Inorganic materials 0.000 description 4
230000002093 peripheral effect Effects 0.000 description 4
239000004033 plastic Substances 0.000 description 4
229920003023 plastic Polymers 0.000 description 4
239000000047 product Substances 0.000 description 4
230000001172 regenerating effect Effects 0.000 description 4
238000000926 separation method Methods 0.000 description 4
230000019491 signal transduction Effects 0.000 description 4
230000035924 thermogenesis Effects 0.000 description 4
230000032258 transport Effects 0.000 description 4
230000008736 traumatic injury Effects 0.000 description 4
VOUAQYXWVJDEQY-QENPJCQMSA-N 33017-11-7 Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 VOUAQYXWVJDEQY-QENPJCQMSA-N 0.000 description 3
206010067484 Adverse reaction Diseases 0.000 description 3
108010075254 C-Peptide Proteins 0.000 description 3
108010078791 Carrier Proteins Proteins 0.000 description 3
229920002307 Dextran Polymers 0.000 description 3
102100033183 Epithelial membrane protein 1 Human genes 0.000 description 3
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
102000003886 Glycoproteins Human genes 0.000 description 3
108090000288 Glycoproteins Proteins 0.000 description 3
102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 description 3
108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 3
101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 description 3
101000763314 Homo sapiens Thrombomodulin Proteins 0.000 description 3
102000004877 Insulin Human genes 0.000 description 3
108090001061 Insulin Proteins 0.000 description 3
102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 description 3
239000007760 Iscove's Modified Dulbecco's Medium Substances 0.000 description 3
108090001090 Lectins Proteins 0.000 description 3
102000004856 Lectins Human genes 0.000 description 3
102000018697 Membrane Proteins Human genes 0.000 description 3
230000004913 activation Effects 0.000 description 3
230000006838 adverse reaction Effects 0.000 description 3
238000002617 apheresis Methods 0.000 description 3
238000005119 centrifugation Methods 0.000 description 3
230000008859 change Effects 0.000 description 3
230000001332 colony forming effect Effects 0.000 description 3
238000012258 culturing Methods 0.000 description 3
210000004292 cytoskeleton Anatomy 0.000 description 3
230000007423 decrease Effects 0.000 description 3
230000001419 dependent effect Effects 0.000 description 3
210000002919 epithelial cell Anatomy 0.000 description 3
210000003754 fetus Anatomy 0.000 description 3
239000011521 glass Substances 0.000 description 3
239000008187 granular material Substances 0.000 description 3
230000012010 growth Effects 0.000 description 3
238000011534 incubation Methods 0.000 description 3
230000015788 innate immune response Effects 0.000 description 3
229940125396 insulin Drugs 0.000 description 3
210000003734 kidney Anatomy 0.000 description 3
239000002523 lectin Substances 0.000 description 3
210000000440 neutrophil Anatomy 0.000 description 3
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
238000012545 processing Methods 0.000 description 3
230000035755 proliferation Effects 0.000 description 3
230000001737 promoting effect Effects 0.000 description 3
238000001228 spectrum Methods 0.000 description 3
230000001225 therapeutic effect Effects 0.000 description 3
239000003440 toxic substance Substances 0.000 description 3
210000003954 umbilical cord Anatomy 0.000 description 3
108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 2
102100022594 ATP-binding cassette sub-family G member 1 Human genes 0.000 description 2
DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
102000007469 Actins Human genes 0.000 description 2
108010085238 Actins Proteins 0.000 description 2
102100020895 Ammonium transporter Rh type A Human genes 0.000 description 2
102100038778 Amphiregulin Human genes 0.000 description 2
102100031092 C-C motif chemokine 3 Human genes 0.000 description 2
102100032532 C-type lectin domain family 10 member A Human genes 0.000 description 2
102100040841 C-type lectin domain family 5 member A Human genes 0.000 description 2
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
108010012236 Chemokines Proteins 0.000 description 2
102000019034 Chemokines Human genes 0.000 description 2
241000222356 Coriolus Species 0.000 description 2
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
101100278839 Drosophila melanogaster sw gene Proteins 0.000 description 2
102000000802 Galectin 3 Human genes 0.000 description 2
108010001517 Galectin 3 Proteins 0.000 description 2
102100028006 Heme oxygenase 1 Human genes 0.000 description 2
108010054147 Hemoglobins Proteins 0.000 description 2
102000001554 Hemoglobins Human genes 0.000 description 2
NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
101001075525 Homo sapiens Ammonium transporter Rh type A Proteins 0.000 description 2
101000777387 Homo sapiens C-C motif chemokine 3 Proteins 0.000 description 2
101000942296 Homo sapiens C-type lectin domain family 10 member A Proteins 0.000 description 2
101000749314 Homo sapiens C-type lectin domain family 5 member A Proteins 0.000 description 2
101100220044 Homo sapiens CD34 gene Proteins 0.000 description 2
101000850989 Homo sapiens Epithelial membrane protein 1 Proteins 0.000 description 2
101001079623 Homo sapiens Heme oxygenase 1 Proteins 0.000 description 2
101000998146 Homo sapiens Interleukin-17A Proteins 0.000 description 2
101001055219 Homo sapiens Interleukin-9 receptor Proteins 0.000 description 2
101001139134 Homo sapiens Krueppel-like factor 4 Proteins 0.000 description 2
101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 2
101000581961 Homo sapiens Neurocalcin-delta Proteins 0.000 description 2
101000851058 Homo sapiens Neutrophil elastase Proteins 0.000 description 2
101000815628 Homo sapiens Regulatory-associated protein of mTOR Proteins 0.000 description 2
101000881267 Homo sapiens Spectrin alpha chain, erythrocytic 1 Proteins 0.000 description 2
101000652747 Homo sapiens Target of rapamycin complex 2 subunit MAPKAP1 Proteins 0.000 description 2
101000979190 Homo sapiens Transcription factor MafB Proteins 0.000 description 2
101000648491 Homo sapiens Transportin-1 Proteins 0.000 description 2
101000934581 Homo sapiens Valacyclovir hydrolase Proteins 0.000 description 2
101000988424 Homo sapiens cAMP-specific 3',5'-cyclic phosphodiesterase 4B Proteins 0.000 description 2
102100034782 Homogentisate 1,2-dioxygenase Human genes 0.000 description 2
102100028888 Hydroxymethylglutaryl-CoA synthase, cytoplasmic Human genes 0.000 description 2
102100033461 Interleukin-17A Human genes 0.000 description 2
102100026244 Interleukin-9 receptor Human genes 0.000 description 2
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
102000008133 Iron-Binding Proteins Human genes 0.000 description 2
108010035210 Iron-Binding Proteins Proteins 0.000 description 2
102100020677 Krueppel-like factor 4 Human genes 0.000 description 2
102100025354 Macrophage mannose receptor 1 Human genes 0.000 description 2
108010031099 Mannose Receptor Proteins 0.000 description 2
108010090314 Member 1 Subfamily G ATP Binding Cassette Transporter Proteins 0.000 description 2
102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 2
206010028980 Neoplasm Diseases 0.000 description 2
102100027348 Neurocalcin-delta Human genes 0.000 description 2
102100033174 Neutrophil elastase Human genes 0.000 description 2
102100026123 Pirin Human genes 0.000 description 2
101710176373 Pirin Proteins 0.000 description 2
239000002202 Polyethylene glycol Substances 0.000 description 2
102100028964 Proteoglycan 3 Human genes 0.000 description 2
101710127914 Proteoglycan 3 Proteins 0.000 description 2
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
108010022999 Serine Proteases Proteins 0.000 description 2
102000012479 Serine Proteases Human genes 0.000 description 2
102100037608 Spectrin alpha chain, erythrocytic 1 Human genes 0.000 description 2
102100023234 Transcription factor MafB Human genes 0.000 description 2
102100028748 Transportin-1 Human genes 0.000 description 2
102100025139 Valacyclovir hydrolase Human genes 0.000 description 2
102100028437 Versican core protein Human genes 0.000 description 2
208000027418 Wounds and injury Diseases 0.000 description 2
239000002253 acid Substances 0.000 description 2
230000004721 adaptive immunity Effects 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
238000010171 animal model Methods 0.000 description 2
238000003556 assay Methods 0.000 description 2
230000037396 body weight Effects 0.000 description 2
210000000988 bone and bone Anatomy 0.000 description 2
102100029168 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human genes 0.000 description 2
229910052791 calcium Inorganic materials 0.000 description 2
239000011575 calcium Substances 0.000 description 2
229910001424 calcium ion Inorganic materials 0.000 description 2
239000000969 carrier Substances 0.000 description 2
230000024245 cell differentiation Effects 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
235000012000 cholesterol Nutrition 0.000 description 2
238000005094 computer simulation Methods 0.000 description 2
230000001276 controlling effect Effects 0.000 description 2
230000007547 defect Effects 0.000 description 2
230000018044 dehydration Effects 0.000 description 2
238000006297 dehydration reaction Methods 0.000 description 2
108700041286 delta Proteins 0.000 description 2
210000004443 dendritic cell Anatomy 0.000 description 2
238000011161 development Methods 0.000 description 2
229940079593 drug Drugs 0.000 description 2
239000004744 fabric Substances 0.000 description 2
150000003278 haem Chemical class 0.000 description 2
230000036039 immunity Effects 0.000 description 2
230000028709 inflammatory response Effects 0.000 description 2
230000003834 intracellular effect Effects 0.000 description 2
231100000518 lethal Toxicity 0.000 description 2
230000001665 lethal effect Effects 0.000 description 2
230000007774 longterm Effects 0.000 description 2
230000005486 microgravity Effects 0.000 description 2
238000013508 migration Methods 0.000 description 2
238000012544 monitoring process Methods 0.000 description 2
210000003643 myeloid progenitor cell Anatomy 0.000 description 2
230000031990 negative regulation of inflammatory response Effects 0.000 description 2
230000001537 neural effect Effects 0.000 description 2
231100000252 nontoxic Toxicity 0.000 description 2
230000003000 nontoxic effect Effects 0.000 description 2
210000004940 nucleus Anatomy 0.000 description 2
230000003204 osmotic effect Effects 0.000 description 2
238000006213 oxygenation reaction Methods 0.000 description 2
230000037361 pathway Effects 0.000 description 2
210000002826 placenta Anatomy 0.000 description 2
229920000728 polyester Polymers 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
238000011176 pooling Methods 0.000 description 2
239000002243 precursor Substances 0.000 description 2
230000002265 prevention Effects 0.000 description 2
230000010076 replication Effects 0.000 description 2
230000004044 response Effects 0.000 description 2
230000009291 secondary effect Effects 0.000 description 2
239000013049 sediment Substances 0.000 description 2
230000011664 signaling Effects 0.000 description 2
241000894007 species Species 0.000 description 2
239000000758 substrate Substances 0.000 description 2
231100000167 toxic agent Toxicity 0.000 description 2
210000004291 uterus Anatomy 0.000 description 2
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
LJRDOKAZOAKLDU-UDXJMMFXSA-N (2s,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-[(2r,3s,4r,5s)-5-[(1r,2r,3s,5r,6s)-3,5-diamino-2-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol;sulfuric ac Chemical compound OS(O)(=O)=O.N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO LJRDOKAZOAKLDU-UDXJMMFXSA-N 0.000 description 1
QIGBRXMKCJKVMJ-UHFFFAOYSA-N 1,4-Benzenediol Natural products OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 1
239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
101150092476 ABCA1 gene Proteins 0.000 description 1
102100026007 ADAM DEC1 Human genes 0.000 description 1
208000030507 AIDS Diseases 0.000 description 1
101150036244 AREG gene Proteins 0.000 description 1
108700005241 ATP Binding Cassette Transporter 1 Proteins 0.000 description 1
102100039338 Aminomethyltransferase, mitochondrial Human genes 0.000 description 1
108050001492 Ammonium transporters Proteins 0.000 description 1
108010033760 Amphiregulin Proteins 0.000 description 1
102100031366 Ankyrin-1 Human genes 0.000 description 1
108010049777 Ankyrins Proteins 0.000 description 1
102000008102 Ankyrins Human genes 0.000 description 1
208000023275 Autoimmune disease Diseases 0.000 description 1
GUBGYTABKSRVRQ-DCSYEGIMSA-N Beta-Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-DCSYEGIMSA-N 0.000 description 1
101710085496 C-X-C motif chemokine 2 Proteins 0.000 description 1
102100036189 C-X-C motif chemokine 3 Human genes 0.000 description 1
102000005701 Calcium-Binding Proteins Human genes 0.000 description 1
108010045403 Calcium-Binding Proteins Proteins 0.000 description 1
201000009030 Carcinoma Diseases 0.000 description 1
102000014914 Carrier Proteins Human genes 0.000 description 1
108010001857 Cell Surface Receptors Proteins 0.000 description 1
102000000844 Cell Surface Receptors Human genes 0.000 description 1
108050000299 Chemokine receptor Proteins 0.000 description 1
102000009410 Chemokine receptor Human genes 0.000 description 1
235000019743 Choline chloride Nutrition 0.000 description 1
102000005853 Clathrin Human genes 0.000 description 1
108010019874 Clathrin Proteins 0.000 description 1
102000002029 Claudin Human genes 0.000 description 1
108050009302 Claudin Proteins 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
108010036949 Cyclosporine Proteins 0.000 description 1
102100027417 Cytochrome P450 1B1 Human genes 0.000 description 1
108010052832 Cytochromes Proteins 0.000 description 1
102000018832 Cytochromes Human genes 0.000 description 1
102000010831 Cytoskeletal Proteins Human genes 0.000 description 1
108010037414 Cytoskeletal Proteins Proteins 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
230000004543 DNA replication Effects 0.000 description 1
102000012545 EGF-like domains Human genes 0.000 description 1
108050002150 EGF-like domains Proteins 0.000 description 1
101150114117 EGR1 gene Proteins 0.000 description 1
102100023226 Early growth response protein 1 Human genes 0.000 description 1
102000016942 Elastin Human genes 0.000 description 1
108010014258 Elastin Proteins 0.000 description 1
UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
108010061932 Factor VIIIa Proteins 0.000 description 1
108010074105 Factor Va Proteins 0.000 description 1
101150071666 HBA gene Proteins 0.000 description 1
102000016761 Haem oxygenases Human genes 0.000 description 1
108050006318 Haem oxygenases Proteins 0.000 description 1
102100026122 High affinity immunoglobulin gamma Fc receptor I Human genes 0.000 description 1
241000282412 Homo Species 0.000 description 1
101000719904 Homo sapiens ADAM DEC1 Proteins 0.000 description 1
101000796140 Homo sapiens Ankyrin-1 Proteins 0.000 description 1
101000947193 Homo sapiens C-X-C motif chemokine 3 Proteins 0.000 description 1
101000725164 Homo sapiens Cytochrome P450 1B1 Proteins 0.000 description 1
101000913074 Homo sapiens High affinity immunoglobulin gamma Fc receptor I Proteins 0.000 description 1
101000872475 Homo sapiens Homogentisate 1,2-dioxygenase Proteins 0.000 description 1
101000839025 Homo sapiens Hydroxymethylglutaryl-CoA synthase, cytoplasmic Proteins 0.000 description 1
101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 description 1
101001019600 Homo sapiens Interleukin-17 receptor B Proteins 0.000 description 1
101000716729 Homo sapiens Kit ligand Proteins 0.000 description 1
101001065660 Homo sapiens Lanosterol synthase Proteins 0.000 description 1
101000990902 Homo sapiens Matrix metalloproteinase-9 Proteins 0.000 description 1
101001064096 Homo sapiens Protein disulfide-thiol oxidoreductase Proteins 0.000 description 1
101001069710 Homo sapiens Serine protease 23 Proteins 0.000 description 1
101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 description 1
101000809875 Homo sapiens TYRO protein tyrosine kinase-binding protein Proteins 0.000 description 1
101000860430 Homo sapiens Versican core protein Proteins 0.000 description 1
102000004157 Hydrolases Human genes 0.000 description 1
108090000604 Hydrolases Proteins 0.000 description 1
229920001612 Hydroxyethyl starch Polymers 0.000 description 1
108010000775 Hydroxymethylglutaryl-CoA synthase Proteins 0.000 description 1
108060003951 Immunoglobulin Proteins 0.000 description 1
208000026350 Inborn Genetic disease Diseases 0.000 description 1
108010017525 Interleukin-17 Receptors Proteins 0.000 description 1
102000004554 Interleukin-17 Receptors Human genes 0.000 description 1
102100035014 Interleukin-17 receptor B Human genes 0.000 description 1
102000015696 Interleukins Human genes 0.000 description 1
108010063738 Interleukins Proteins 0.000 description 1
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
102100032011 Lanosterol synthase Human genes 0.000 description 1
102100030412 Matrix metalloproteinase-9 Human genes 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
101100219997 Mus musculus Ccr1 gene Proteins 0.000 description 1
102100035083 Myoferlin Human genes 0.000 description 1
108050006329 Myoferlin Proteins 0.000 description 1
OVRNDRQMDRJTHS-CBQIKETKSA-N N-Acetyl-D-Galactosamine Chemical group CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-CBQIKETKSA-N 0.000 description 1
108010077960 Neurocalcin Proteins 0.000 description 1
102000010751 Neurocalcin Human genes 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
108090000854 Oxidoreductases Proteins 0.000 description 1
102000004316 Oxidoreductases Human genes 0.000 description 1
108090000417 Oxygenases Proteins 0.000 description 1
102000004020 Oxygenases Human genes 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
206010057249 Phagocytosis Diseases 0.000 description 1
102100033616 Phospholipid-transporting ATPase ABCA1 Human genes 0.000 description 1
241000288906 Primates Species 0.000 description 1
102000029797 Prion Human genes 0.000 description 1
108091000054 Prion Proteins 0.000 description 1
239000004365 Protease Substances 0.000 description 1
102000004245 Proteasome Endopeptidase Complex Human genes 0.000 description 1
108090000708 Proteasome Endopeptidase Complex Proteins 0.000 description 1
108010029485 Protein Isoforms Proteins 0.000 description 1
102000001708 Protein Isoforms Human genes 0.000 description 1
102000001253 Protein Kinase Human genes 0.000 description 1
102100030728 Protein disulfide-thiol oxidoreductase Human genes 0.000 description 1
230000010799 Receptor Interactions Effects 0.000 description 1
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
102100033835 Serine protease 23 Human genes 0.000 description 1
102100038081 Signal transducer CD24 Human genes 0.000 description 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
210000001744 T-lymphocyte Anatomy 0.000 description 1
102100038717 TYRO protein tyrosine kinase-binding protein Human genes 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
108090000190 Thrombin Proteins 0.000 description 1
108010079274 Thrombomodulin Proteins 0.000 description 1
102100033663 Transforming growth factor beta receptor type 3 Human genes 0.000 description 1
WYHIICXRPHEJKI-UHFFFAOYSA-N Trientine hydrochloride Chemical compound Cl.Cl.NCCNCCNCCN WYHIICXRPHEJKI-UHFFFAOYSA-N 0.000 description 1
GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
108090000704 Tubulin Proteins 0.000 description 1
102000004243 Tubulin Human genes 0.000 description 1
108090000848 Ubiquitin Proteins 0.000 description 1
102000044159 Ubiquitin Human genes 0.000 description 1
101710200894 Versican core protein Proteins 0.000 description 1
102100038138 WD repeat-containing protein 26 Human genes 0.000 description 1
XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000009471 action Effects 0.000 description 1
230000033289 adaptive immune response Effects 0.000 description 1
230000001464 adherent effect Effects 0.000 description 1
239000003570 air Substances 0.000 description 1
WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical group OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
239000012080 ambient air Substances 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
239000003708 ampul Substances 0.000 description 1
208000007502 anemia Diseases 0.000 description 1
230000003110 anti-inflammatory effect Effects 0.000 description 1
230000003409 anti-rejection Effects 0.000 description 1
239000003146 anticoagulant agent Substances 0.000 description 1
229940127219 anticoagulant drug Drugs 0.000 description 1
230000005775 apoptotic pathway Effects 0.000 description 1
LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 description 1
210000003719 b-lymphocyte Anatomy 0.000 description 1
210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
108010079292 betaglycan Proteins 0.000 description 1
230000027455 binding Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
239000012503 blood component Substances 0.000 description 1
230000036760 body temperature Effects 0.000 description 1
210000002798 bone marrow cell Anatomy 0.000 description 1
230000034127 bone morphogenesis Effects 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
231100000504 carcinogenesis Toxicity 0.000 description 1
230000000747 cardiac effect Effects 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
230000021164 cell adhesion Effects 0.000 description 1
230000006369 cell cycle progression Effects 0.000 description 1
230000011712 cell development Effects 0.000 description 1
230000003915 cell function Effects 0.000 description 1
230000012292 cell migration Effects 0.000 description 1
230000009087 cell motility Effects 0.000 description 1
239000002458 cell surface marker Substances 0.000 description 1
239000006285 cell suspension Substances 0.000 description 1
230000003833 cell viability Effects 0.000 description 1
210000002421 cell wall Anatomy 0.000 description 1
230000017455 cell-cell adhesion Effects 0.000 description 1
230000010267 cellular communication Effects 0.000 description 1
230000030570 cellular localization Effects 0.000 description 1
230000019522 cellular metabolic process Effects 0.000 description 1
230000005754 cellular signaling Effects 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
230000001659 chemokinetic effect Effects 0.000 description 1
230000003399 chemotactic effect Effects 0.000 description 1
230000035605 chemotaxis Effects 0.000 description 1
SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
229960003178 choline chloride Drugs 0.000 description 1
229960001265 ciclosporin Drugs 0.000 description 1
229930193282 clathrin Natural products 0.000 description 1
238000009643 clonogenic assay Methods 0.000 description 1
231100000096 clonogenic assay Toxicity 0.000 description 1
238000005345 coagulation Methods 0.000 description 1
230000015271 coagulation Effects 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
238000011109 contamination Methods 0.000 description 1
239000013068 control sample Substances 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
239000013078 crystal Substances 0.000 description 1
230000001186 cumulative effect Effects 0.000 description 1
229930182912 cyclosporin Natural products 0.000 description 1
108010057085 cytokine receptors Proteins 0.000 description 1
102000003675 cytokine receptors Human genes 0.000 description 1
230000000254 damaging effect Effects 0.000 description 1
230000034994 death Effects 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
230000003413 degradative effect Effects 0.000 description 1
230000001066 destructive effect Effects 0.000 description 1
238000001784 detoxification Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
229940119744 dextran 40 Drugs 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
208000037765 diseases and disorders Diseases 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
230000003828 downregulation Effects 0.000 description 1
229920002549 elastin Polymers 0.000 description 1
239000000806 elastomer Substances 0.000 description 1
229920001971 elastomer Polymers 0.000 description 1
230000005684 electric field Effects 0.000 description 1
230000005672 electromagnetic field Effects 0.000 description 1
210000002472 endoplasmic reticulum Anatomy 0.000 description 1
210000002889 endothelial cell Anatomy 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
210000003979 eosinophil Anatomy 0.000 description 1
230000009786 epithelial differentiation Effects 0.000 description 1
UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
230000007717 exclusion Effects 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
230000001605 fetal effect Effects 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
238000001914 filtration Methods 0.000 description 1
230000004927 fusion Effects 0.000 description 1
229930182830 galactose Natural products 0.000 description 1
230000002496 gastric effect Effects 0.000 description 1
238000003500 gene array Methods 0.000 description 1
238000001415 gene therapy Methods 0.000 description 1
208000016361 genetic disease Diseases 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
230000002414 glycolytic effect Effects 0.000 description 1
210000002288 golgi apparatus Anatomy 0.000 description 1
238000012388 gravitational sedimentation Methods 0.000 description 1
239000000122 growth hormone Substances 0.000 description 1
230000009931 harmful effect Effects 0.000 description 1
230000036541 health Effects 0.000 description 1
210000003958 hematopoietic stem cell Anatomy 0.000 description 1
208000006454 hepatitis Diseases 0.000 description 1
231100000283 hepatitis Toxicity 0.000 description 1
229960001340 histamine Drugs 0.000 description 1
230000003054 hormonal effect Effects 0.000 description 1
102000055151 human KITLG Human genes 0.000 description 1
230000003301 hydrolyzing effect Effects 0.000 description 1
229940050526 hydroxyethylstarch Drugs 0.000 description 1
208000026278 immune system disease Diseases 0.000 description 1
102000018358 immunoglobulin Human genes 0.000 description 1
230000006872 improvement Effects 0.000 description 1
229940073062 imuran Drugs 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
230000006698 induction Effects 0.000 description 1
230000002458 infectious effect Effects 0.000 description 1
230000002757 inflammatory effect Effects 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
230000000266 injurious effect Effects 0.000 description 1
230000010053 inner ear morphogenesis Effects 0.000 description 1
CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
238000009413 insulation Methods 0.000 description 1
108010093036 interleukin receptors Proteins 0.000 description 1
102000002467 interleukin receptors Human genes 0.000 description 1
229940047122 interleukins Drugs 0.000 description 1
210000003963 intermediate filament Anatomy 0.000 description 1
210000005061 intracellular organelle Anatomy 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
210000002510 keratinocyte Anatomy 0.000 description 1
208000032839 leukemia Diseases 0.000 description 1
230000004322 lipid homeostasis Effects 0.000 description 1
230000004807 localization Effects 0.000 description 1
230000007762 localization of cell Effects 0.000 description 1
210000004698 lymphocyte Anatomy 0.000 description 1
210000005210 lymphoid organ Anatomy 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
230000036210 malignancy Effects 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
210000001161 mammalian embryo Anatomy 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
210000002901 mesenchymal stem cell Anatomy 0.000 description 1
HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
108020004999 messenger RNA Proteins 0.000 description 1
239000002184 metal Substances 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
230000003228 microsomal effect Effects 0.000 description 1
230000005012 migration Effects 0.000 description 1
230000002438 mitochondrial effect Effects 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000009456 molecular mechanism Effects 0.000 description 1
210000005087 mononuclear cell Anatomy 0.000 description 1
210000002894 multi-fate stem cell Anatomy 0.000 description 1
210000000066 myeloid cell Anatomy 0.000 description 1
210000004165 myocardium Anatomy 0.000 description 1
210000000822 natural killer cell Anatomy 0.000 description 1
230000010309 neoplastic transformation Effects 0.000 description 1
229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
238000010606 normalization Methods 0.000 description 1
210000000633 nuclear envelope Anatomy 0.000 description 1
238000010899 nucleation Methods 0.000 description 1
239000002777 nucleoside Substances 0.000 description 1
150000003833 nucleoside derivatives Chemical class 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
210000003463 organelle Anatomy 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
238000010827 pathological analysis Methods 0.000 description 1
229960001639 penicillamine Drugs 0.000 description 1
230000010412 perfusion Effects 0.000 description 1
239000012466 permeate Substances 0.000 description 1
230000008782 phagocytosis Effects 0.000 description 1
230000003169 placental effect Effects 0.000 description 1
231100000614 poison Toxicity 0.000 description 1
229920000098 polyolefin Polymers 0.000 description 1
229920006316 polyvinylpyrrolidine Polymers 0.000 description 1
230000023603 positive regulation of transcription initiation, DNA-dependent Effects 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
230000035935 pregnancy Effects 0.000 description 1
238000004321 preservation Methods 0.000 description 1
230000037452 priming Effects 0.000 description 1
229940002612 prodrug Drugs 0.000 description 1
239000000651 prodrug Substances 0.000 description 1
230000000770 proinflammatory effect Effects 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
238000011321 prophylaxis Methods 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
230000007065 protein hydrolysis Effects 0.000 description 1
108060006633 protein kinase Proteins 0.000 description 1
230000004144 purine metabolism Effects 0.000 description 1
238000004064 recycling Methods 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000026267 regulation of growth Effects 0.000 description 1
210000003289 regulatory T cell Anatomy 0.000 description 1
230000002629 repopulating effect Effects 0.000 description 1
230000000241 respiratory effect Effects 0.000 description 1
230000029058 respiratory gaseous exchange Effects 0.000 description 1
230000011506 response to oxidative stress Effects 0.000 description 1
HEBKCHPVOIAQTA-ZXFHETKHSA-N ribitol Chemical compound OC[C@H](O)[C@H](O)[C@H](O)CO HEBKCHPVOIAQTA-ZXFHETKHSA-N 0.000 description 1
239000012266 salt solution Substances 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
210000002027 skeletal muscle Anatomy 0.000 description 1
208000017520 skin disease Diseases 0.000 description 1
238000010583 slow cooling Methods 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000007787 solid Substances 0.000 description 1
210000001988 somatic stem cell Anatomy 0.000 description 1
229960002920 sorbitol Drugs 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
210000001550 testis Anatomy 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
229960004072 thrombin Drugs 0.000 description 1
210000001541 thymus gland Anatomy 0.000 description 1
210000001578 tight junction Anatomy 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
108700012359 toxins Proteins 0.000 description 1
230000026683 transduction Effects 0.000 description 1
238000010361 transduction Methods 0.000 description 1
230000001052 transient effect Effects 0.000 description 1
108091005703 transmembrane proteins Proteins 0.000 description 1
102000035160 transmembrane proteins Human genes 0.000 description 1
239000012780 transparent material Substances 0.000 description 1
229960002408 trientine hydrochloride Drugs 0.000 description 1
210000004881 tumor cell Anatomy 0.000 description 1
230000007306 turnover Effects 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
230000027285 ultradian rhythm Effects 0.000 description 1
230000003827 upregulation Effects 0.000 description 1
230000028973 vesicle-mediated transport Effects 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
238000011179 visual inspection Methods 0.000 description 1
238000012800 visualization Methods 0.000 description 1
239000002676 xenobiotic agent Substances 0.000 description 1
230000004572 zinc-binding Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M27/00—Means for mixing, agitating or circulating fluids in the vessel
- C12M27/10—Rotating vessel
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M35/00—Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
- C12M35/02—Electrical or electromagnetic means, e.g. for electroporation or for cell fusion
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2525/00—Culture process characterised by gravity, e.g. microgravity
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2529/00—Culture process characterised by the use of electromagnetic stimulation

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Biomedical Technology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
Hematology (AREA)
Diabetes (AREA)
Immunology (AREA)
Cell Biology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Sustainable Development (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Emergency Medicine (AREA)
Obesity (AREA)
Physics & Mathematics (AREA)
Electromagnetism (AREA)
Gastroenterology & Hepatology (AREA)
Endocrinology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

CA002597972A 2007-08-20 2007-08-20 Methode et composition de traitement du diabete Abandoned CA2597972A1 (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA002597972A CA2597972A1 (fr)	2007-08-20	2007-08-20	Methode et composition de traitement du diabete

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA002597972A CA2597972A1 (fr)	2007-08-20	2007-08-20	Methode et composition de traitement du diabete

Publications (1)

Publication Number	Publication Date
CA2597972A1 true CA2597972A1 (fr)	2009-02-20

Family

ID=40374842

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002597972A Abandoned CA2597972A1 (fr)	2007-08-20	2007-08-20	Methode et composition de traitement du diabete

Country Status (1)

Country	Link
CA (1)	CA2597972A1 (fr)

2007
- 2007-08-20 CA CA002597972A patent/CA2597972A1/fr not_active Abandoned

Publication	Publication Date	Title
US20080075700A1 (en)	2008-03-27	Method and composition for treating diabetes
US20080057042A1 (en)	2008-03-06	Method of providing readily available cellular material derived from cord blood, and a composition thereof
US20080050348A1 (en)	2008-02-28	Method and composition for repairing heart tissue
US20070117087A1 (en)	2007-05-24	Method of providing readily available cellular material derived from peripheral blood, and a compositoin thereof
CA2596083A1 (fr)	2006-08-03	Procede d'obtention de materiau cellulaire derive de sang de cordon facilement utilisable, et compositions correspondantes
US20080075704A1 (en)	2008-03-27	Method of providing readily available cellular material derived from peripheral blood, and a composition thereof
US20080171020A1 (en)	2008-07-17	Method and composition for repairing epithelial and other cells and tissue
US20060193836A1 (en)	2006-08-31	Method and composition for repairing heart tissue
WO2009025723A1 (fr)	2009-02-26	Procédé et composition pour traiter une affection diabétique
US20060193838A1 (en)	2006-08-31	Method and composition for treating diabetes
CA2597963A1 (fr)	2009-02-20	Methode d'obtention de substance cellulaire facilement disponible derivee du sang peripherique et composition de cette substance
CA2597972A1 (fr)	2009-02-20	Methode et composition de traitement du diabete
CA2595744A1 (fr)	2009-02-01	Procede d'obtention de materiau cellulaire derive de sang de cordon facilement utilisable, et composition correspondante
CA2597971A1 (fr)	2009-02-20	Methode et composition servant a reparer des cellules epitheliales ou d'autres types de cellules et de tissus
CA2597954A1 (fr)	2009-02-20	Methode et composition de reparation de tissu cardiaque
WO2007058929A2 (fr)	2007-05-24	Composition permettant de reduire les problemes associes a la drepanocytose utilisant un stockage a basse temperature
CN101160046A (zh)	2008-04-09	提供容易获得的源于外周血的细胞材料的方法及其组合物
Lindsey et al.	2011	The Importance of Physiologically Inspired Physicochemical Parameters on Hematopoietic Stem-Cell Maintenance and Lineage-Specific Differentiation
MX2007010452A (es)	2008-10-03	Metodo y composiciones para reparar celulas y tejido epitelial y otros

Legal Events

Date	Code	Title	Description
2010-08-20	FZDE	Discontinued